Venture-backed AbCellera buys Silicon Valley’s Trianni

AbCellera, a Vancouver, British Columbia-based developer of therapeutic antibodies, has acquired Trianni, a San Francisco-based specialist in antibody discovery technology using transgenic mice.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this